Zimbabwe has turned down a substantial US healthcare agreement worth $367m (£272m) over five years because of the United States' insistence on sensitive data.
This rejection was revealed following a official document dated December was leaked, indicating that President Emmerson Mnangagwa believed the deal was "lopsided".
A government spokesman later stated that the United States was seeking genetic material for research and commercial purposes but was unwilling to share the resulting advantages from any future treatments.
"We will now turn to the challenging and unfortunate task of ending our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had provided more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has urged continued talks to reach a agreement agreeable to both sides so the nation's vital HIV treatment initiative can continue.
Wider Context
Zimbabwe's decision follows a comparable situation in neighbouring Kenya, where a high court halted a related health funding agreement after legal challenges were filed about the safety of citizens' medical information.
Since returning to office last year, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).
The agency had administered aid for the American government, but Trump claimed its expenditure was "wasteful" and his administration was seeking government-to-government agreements to enhance transparency and accountability.
As per statements, Sixteen African countries have to date signed these new health pacts, constituting more than $18.3bn of fresh investment.
Details of the Rejected Agreement
The money for Zimbabwe was intended to supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this collaboration might have yielded immense advantages for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving HIV treatment through US-supported programmes," the Ambassador said.
However, official spokesman Nick Mangwana said the proposed deal was "asymmetrical".
"Our nation was requested to surrender its genetic material and health information for a long time, without any corresponding guarantee of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that shared data," his statement read.
"Effectively, our nation would provide the basic resources for medical research without any certainty that the end products would be accessible to our population should a new pandemic emerge."
National Interest and Global Health
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were disrupting frameworks already set up through the international health agency.
The spokesperson cited its Pandemic Benefit-Sharing system created to deal with future pandemics.
"This mechanism is intended to ensure that when a country contributes its samples, the resulting advantages – including medicines and cures – are shared equitably, not monopolised solely by those with the funds to develop them."
Zimbabwe's reservations over the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We encourage continued discussions with our American counterparts on how future co-operation might be structured in a way that respects the sovereignty and interests of both nations."
Health Experts Response
Medical experts expressed it understood the government's concerns, but recommended that negotiations need to persist since a large portion of the country's Aids initiatives depended on external financing.
"If technical issues exist, including those involving information security or implementation frameworks, these can often be addressed via detailed discussion and mutually agreed protections," it said.
This impasse underscores the continuing debate between accepting much-needed international aid and safeguarding national sovereignty in an increasingly data-driven world.